Association study of the elastin microfibril interfacer 1 (EMILIN1) gene in essential hypertension

American Journal of Hypertension

Volumn 23, Issue 5, 2010, Pages 547-555

  Shimodaira, Masanori ^a,b   Nakayama, Tomohiro ^a,b   Sato, Naoyuki ^a   Naganuma, Takahiro ^a   Yamaguchi, Mai ^a   Aoi, Noriko ^a   Sato, Mikano ^a   Izumi, Yoichi ^a   Soma, Masayoshi ^a   Matsumoto, Koichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

Author keywords

Androgen; Blood pressure; Case control study; EMILIN1; Essential hypertension; Haplotype; Hypertension; Single nucleotide polymorphism

Indexed keywords

ANDROGEN; ELASTIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BLOOD PRESSURE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELASTIN MICROFIBRIL INTERFACER 1 GENE; ESSENTIAL HYPERTENSION; FEMALE; GENE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; JAPAN; LOGISTIC MODELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS;

EID: 77951142700     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.16     Document Type: Article

References (30)

1. Stokes J 3rd, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study-30 years of follow-up. Hypertension 1989; 13:I13-I18.
2. Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999; 340: 1221-1227.
3. Barri YM. Hypertension and kidney disease: a deadly connection. Curr Cardiol Rep 2006; 8:411-417.
4. Lifton R P, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
5. Faury G, Pezet M, Knutsen RH, Boyle WA, Heximer S P, McLean SE, Minkes RK, Blumer KJ, Kovacs A, Kelly D P, Li DY, Starcher B, Mecham R P. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. J Clin Invest 2003; 112:1419-1428.
6. Arteaga-Solis E, Gayraud B, Ramirez F. Elastic and collagenous networks in vascular diseases. Cell Struct Funct 2000; 25:69-72.
7. Roberts AB, McCune BK, Sporn MB. TGF-beta: regulation of extracellular matrix. Kidney Int 1992; 41:557-559.
8. Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998; 31:181-188.
9. Zacchigna L, Vecchione C, Notte A, Cordenonsi M, Dupont S, Maretto S, Cifelli G, Ferrari A, Maffei A, Fabbro C, Braghetta P, Marino G, Selvetella G, Aretini A, Colonnese C, Bettarini U, Russo G, Soligo S, Adorno M, Bonaldo P, Volpin D, Piccolo S, Lembo G, Bressan GM. Emilin1 links TGF-beta maturation to blood pressure homeostasis. Cell 2006; 124:929-942.
10. Lijnen PJ, Petrov VV, Fagard RH. Association between transforming growth factor-beta and hypertension. Am J Hypertens 2003; 16:604-611.
11. Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999; 33: 271-275.
12. Doliana R, Canton A, Bucciotti F, Mongiat M, Bonaldo P, Colombatti A. Structure, chromosomal localization, and promoter analysis of the human elastin microfibril interfase located proteIN (EMILIN) gene. J Biol Chem 2000; 275:785-792.
13. Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-183.
14. Haketa A, Soma M, Nakayama T, Sato M, Kosuge K, Aoi N, Matsumoto K. Two medium-chain acyl-coenzyme A synthetase genes, SAH and MACS1, are associated with plasma high-density lipoprotein cholesterol levels, but they are not associated with essential hypertension. J Hypertens 2004; 22: 1903-1907.
15. Nakayama T, Soma M, Rahmutula D, Ozawa Y, Kanmatsuse K. Isolation of the 5′-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. Med Sci Monit 2001; 7:345-349.
16. Sano M, Kuroi N, Nakayama T, Sato N, Izumi Y, Soma M, Kokubun S. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens 2005; 18:403-408.
17. Livak KJ, Marmaro J, Todd JA. Towards fully automated genome-wide polymorphism screening. Nat Genet 1995; 9:341-342.
18. Olson JM, Wijsman EM. Design and sample-size considerations in the detection of linkage disequilibrium with a disease locus. Am J Hum Genet 1994; 55: 574-580.
19. Dempster A P, Laird NM, Rubin DB. Maximum likelihood from in complete data via the EM algorithm. J R Stat Soc 1977; 39:1-22.
20. Massagué J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103:295-309.
21. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and\or target organ damage. Proc Natl Acad Sci USA 2000; 97:3479-3484.
22. Chun TY, Chander PN, Kim JW, Pratt JH, Stier CT Jr. Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 2008; 295:E305-E312.
23. Zanetti M, Braghetta P, Sabatelli P, Mura I, Doliana R, Colombatti A, Volpin D, Bonaldo P, Bressan GM. EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol Cell Biol 2004; 24:638-650.
24. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000; 101: 2783-2787.
25. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97:1766-1772.
26. Ono K, Mannami T, Iwai N. Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women. J Hypertens 2003; 21: 1497-1503.
27. Yamada Y, Fujisawa M, Ando F, Niino N, Tanaka M, Shimokata H. Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals. J Hum Genet 2002; 47:243-248.
28. Ivanov V P, Solodilova MA, Polonnikov AV, Belugin DA, Shestakov AM, Ushachev DV, Khoroshaya IV, Katargina LN, Kozhukhov MA, Kolesnikova OE. Arg25Pro polymorphism of transforming growth factor-beta1 and its role in the pathogenesis of essential hypertension in Russian population of the Central Chernozem Region. Bull Exp Biol Med 2007; 144:66-68.
29. Shen C, Lu X, Li Y, Zhao Q, Liu X, Hou L, Wang L, Chen S, Huang J, Gu D. Emilin1 gene and essential hypertension: a two-stage association study in northern Han Chinese population. BMC Med Genet 2009; 10:118.
30. Sadeghi M, Daniel V, Naujokat C, Weimer R, Opelz G. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury? Clin Exp Immunol 2005; 142:312-317.